Raymond James Upgrades ICU Medical to Outperform, Announces $135 Price Target
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has upgraded ICU Medical (NASDAQ:ICUI) from Market Perform to Outperform and set a price target of $135.
June 17, 2024 | 4:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James has upgraded ICU Medical from Market Perform to Outperform and set a price target of $135.
The upgrade from Market Perform to Outperform by a reputable analyst at Raymond James, along with a specific price target of $135, is likely to positively influence investor sentiment and drive short-term price appreciation for ICU Medical.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100